Want to see FR:ALTUV full AI Analyst Report?
Top Page
Bio-UV Group SA
(ALTUV)
Select Model
Select Model
Rating:53Neutral
Price Target:
€0.83
▼(-38.82% Downside)
Action:Reiterated
Date:10/17/26
The score is held up by improving and consistently positive cash generation and a reasonably stable balance sheet. Offsetting this, technicals are very weak (price well below key moving averages with negative MACD and extremely oversold momentum), and valuation is demanding with a ~94.8 P/E and no dividend yield provided. Mixed operating performance—declining revenue and inconsistent profitability—adds uncertainty.
Positive Factors
Consistently positive cash generation
Sustained positive operating and free cash flow supports liquidity and gives Bio-UV internally generated resources to fund operations, service debt, and reinvest in growth. The improvement into 2024–2025 also indicates stronger conversion of business activity into discretionary cash.
Negative Factors
Declining recent revenue
Revenue contraction limits operating leverage and makes it harder for fixed engineering, production, and commercial resources to be absorbed efficiently. Unless growth returns, weaker scale can constrain profit expansion and reduce the financial capacity available for sustained investment.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistently positive cash generation
Sustained positive operating and free cash flow supports liquidity and gives Bio-UV internally generated resources to fund operations, service debt, and reinvest in growth. The improvement into 2024–2025 also indicates stronger conversion of business activity into discretionary cash.
Read all positive factors
Bio-UV Group SA (ALTUV) vs. iShares MSCI France ETF (EWQ)
Market Cap
€11.62M
Dividend Yield1.96%
Average Volume (3M)21.19K
Price to Earnings (P/E)87.8
Beta (1Y)0.38
Revenue Growth-5.75%
EPS Growth-78.66%
CountryFR
Employees143
SectorIndustrials
Sector Strength72
IndustryIndustrial - Pollution & Treatment Controls
Share Statistics
EPS (TTM)N/A
Shares Outstanding14,154,679
10 Day Avg. Volume30,964
30 Day Avg. Volume21,189
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.52
Price to Sales (P/S)0.58
P/FCF Ratio6.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bio-UV Group SA Business Overview & Revenue Model
Company Description
Based in Lunel, France, BIO-UV Group S.A. specializes in the conception, production, and commercialization of ultraviolet (UV) light systems for the purification of water and disinfection of surfaces. Serving both private individuals and professio...
How the Company Makes Money
Bio-UV Group SA makes money primarily by selling water treatment equipment and associated services across its target markets. Key revenue streams include: (1) Sale of UV disinfection systems and related treatment units: the company generates reven...
Bio-UV Group SA Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
63
Positive
Cash Flow
72
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.59M | 35.90M | 39.58M | 43.13M | 51.29M | 33.46M |
| Gross Profit | 1.46M | 2.00M | 24.09M | 25.58M | 4.71M | 1.84M |
| EBITDA | 212.97K | 1.60M | 4.18M | 4.43M | 6.38M | 3.35M |
| Net Income | 187.83K | 836.34K | 31.36K | 124.89K | 2.42M | 689.38K |
Balance Sheet | ||||||
| Total Assets | 71.98M | 69.21M | 66.09M | 71.41M | 74.08M | 81.12M |
| Cash, Cash Equivalents and Short-Term Investments | 7.75M | 10.18M | 3.87M | 2.73M | 1.98M | 10.57M |
| Total Debt | 18.44M | 20.23M | 23.99M | 28.27M | 29.15M | 30.74M |
| Total Liabilities | 30.84M | 28.68M | 33.40M | 39.19M | 41.74M | 50.43M |
| Stockholders Equity | 41.08M | 40.47M | 32.69M | 32.22M | 32.24M | 30.52M |
Cash Flow | ||||||
| Free Cash Flow | 1.82M | 3.00M | 5.00M | 4.28M | 476.03K | 571.69K |
| Operating Cash Flow | 3.33M | 4.63M | 6.90M | 6.24M | 2.70M | 3.30M |
| Investing Cash Flow | -1.53M | -1.60M | -1.87M | -1.95M | -8.95M | -20.70M |
| Financing Cash Flow | -3.05M | 3.37M | -3.73M | -3.57M | -2.50M | 15.53M |
Bio-UV Group SA Technical Analysis
Negative
1.36
Price Trends
1.20
Negative
1.27
Negative
1.32
Negative
Market Momentum
-0.10
Positive
17.35
Positive
13.58
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALTUV, the sentiment is Negative. The current price of 1.36 is above the 20-day moving average (MA) of 1.03, above the 50-day MA of 1.20, and above the 200-day MA of 1.32, indicating a bearish trend. The MACD of -0.10 indicates Positive momentum. The RSI at 17.35 is Positive, neither overbought nor oversold. The STOCH value of 13.58 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALTUV.
Bio-UV Group SA Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | €1.22B | 9.36 | 11.53% | 1.67% | -2.88% | 24.77% | |
55 Neutral | €23.44B | 19.06 | 17.55% | 4.68% | -0.13% | 12.40% | |
53 Neutral | €11.62M | 87.84 | ― | 1.96% | -5.75% | -78.66% | |
53 Neutral | €562.41M | 31.92 | 2.68% | 1.64% | 2.29% | -59.18% | |
42 Neutral | €13.48M | -1.07 | 19.27% | ― | 61.30% | -6.66% |
* Industrials Sector Average
FR:ALTUV
Bio-UV Group SA
0.89
-0.66
-42.71%
FR:DBG
Derichebourg
7.62
1.52
24.90%
FR:SCHP
Seche Environnement
73.80
-1.62
-2.15%
FR:VIE
Veolia Environnement
31.82
3.41
12.01%
FR:OREGE
Orege SA
0.27
>-0.01
-3.26%
FR:GPE
Groupe Pizzorno Environnement SA
62.15
5.91
10.51%
Bio-UV Group SA Corporate Events
Bio-UV Group boosts liquidity contract resources to support share stability
Oct 20, 2026
Bio-UV Group SA has increased the cash resources allocated to its liquidity contract with Invest Securities by €80,000 as of 20 October 2026, in line with French market regulator AMF rules. The move is aimed at improving the liquidity of the...
BIO-UV Group Cuts 2026 Revenue Guidance Amid Geopolitical Delays
Oct 16, 2026
BIO-UV Group has revised its 2026 revenue outlook to a range of €35 million to €39 million, down from a previous forecast of €38 million to €42 million, reflecting a 7% adjustment. The change is mainly driven by longer deci...
BIO-UV Group Holds Revenue Steady, Narrows Margins but Reaffirms 2026 Growth Targets
Sep 18, 2026
BIO-UV Group reported first-half 2026 revenue of €20.1m, broadly flat year-on-year, as robust growth in its Solutions and Services Aftermarket divisions offset a 13% decline in Products sales amid salesforce reorganisation and weaker French...
BIO-UV Group Details Mid-2026 Liquidity Contract Activity
Sep 8, 2026
BIO-UV Group reported the mid-2026 status of the liquidity contract it has entrusted to All Invest for its shares listed on Euronext Growth. As of 30 June 2026, the liquidity account held 65,162 shares and a cash balance of €77,350.38, compa...
BIO-UV Group Holds Revenue Steady as Services and Solutions Drive 2026 Rebound
Jul 23, 2026
BIO-UV Group reported first-half 2026 revenue of €20.1 million, essentially flat year-on-year, as double-digit growth in Services After-Sales and a 4% rebound in the Solutions division offset a 13% decline in Products tied to salesforce reo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.